Showing results (11-20 of 97) with videos related to
Sort By:
Pageof 10
Blood|August 9, 2003
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humansMarta Stanzani, Sergio L R Martins, Rima M Saliba, et al.Transfusion|February 11, 2017
Patient age and number of apheresis days may predict development of secondary myelodysplastic syndrome and acute myelogenous leukemia after high-dose chemotherapy and autologous stem cell transplantation for lymphomaIsabell Ge, Rima M Saliba, Farzaneh Maadani, et al.Experimental Hematology|January 17, 2004
Nonablative allogeneic stem cell transplantation for chronic lymphocytic leukemia: impact of rituximab on immunomodulation and survivalIssa F Khouri, Ming-Sheng Lee, Rima M Saliba, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 24, 2007
Results of a retrospective single institution analysis of targeted skeletal radiotherapy with (166)Holmium-DOTMP as conditioning regimen for autologous stem cell transplant for patients with multiple myeloma. Impact on transplant outcomesAnna V Christoforidou, Rima M Saliba, Patricia Williams, et al.Transfusion|September 28, 2006
Recombinant human granulocyte-colony-stimulating factor-mobilized and apheresis-collected endothelial progenitor cells: a novel blood cell component for therapeutic vasculogenesisMartin Körbling, James M Reuben, Hui Gao, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 2010
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 lociStefan O Ciurea, Rima M Saliba, Gabriela Rondon, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2004
Nonmyeloablative allogeneic hematopoietic transplantation: a promising salvage therapy for patients with non-Hodgkin's lymphoma whose disease has failed a prior autologous transplantationMaricer P Escalón, Richard E Champlin, Rima M Saliba, et al.British Journal of Haematology|April 26, 2007
Graft-versus-leukaemia effect after non-myeloablative haematopoietic transplantation can overcome the unfavourable expression of ZAP-70 in refractory chronic lymphocytic leukaemiaIssa F Khouri, Rima M Saliba, Joan Admirand, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 18, 2015
Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic SyndromesHans C Lee, Rima M Saliba, Gabriela Rondon, et al.Leukemia & Lymphoma|August 23, 2006
High-dose rituximab does not negatively affect peripheral blood stem cell mobilization kinetics in patients with intermediate-grade non-Hodgkin's lymphomaChitra Hosing, Rima M Saliba, Martin Körbling, et al.Pageof 10